McKesson Reports Strong Fiscal Q3 Earnings

Prescription drug distributor exceeds Wall Street expectations on revenue and adjusted earnings per share.

Feb. 4, 2026 at 4:23pm

Got story updates? Submit your updates here. ›

McKesson Corporation, a major pharmaceutical distributor, reported fiscal third-quarter earnings of $1.19 billion, or $9.59 per share. Adjusted earnings per share came in at $9.34, beating the average analyst estimate of $9.31. The company also posted revenue of $106.16 billion, surpassing the $105.66 billion expected by analysts.

Why it matters

McKesson's strong quarterly performance demonstrates the company's ability to navigate the complex pharmaceutical supply chain and distribution landscape. As a leading drug distributor, McKesson's results are closely watched as an indicator of broader industry trends and the health of the healthcare sector.

The details

McKesson reported net income of $1.19 billion, or $9.59 per share, for the fiscal third quarter. Adjusted for non-recurring gains, the company's earnings per share came in at $9.34, exceeding the average analyst estimate of $9.31 per share. On the revenue side, McKesson posted $106.16 billion, topping the $105.66 billion expected by analysts surveyed by Zacks Investment Research.

  • McKesson reported its fiscal third-quarter earnings on Wednesday, February 4, 2026.

The players

McKesson Corporation

A major pharmaceutical distributor and healthcare services company headquartered in Irving, Texas.

Got photos? Submit your photos here. ›

The takeaway

McKesson's strong quarterly results demonstrate the company's ability to effectively manage the complexities of the pharmaceutical supply chain and distribution network, positioning it well to continue serving the healthcare industry.